Basic Science and Pathogenesis

Fadhl Al-Shaebi, Sudipta Senapati, Alessia Sciortino, Marina Farag, Madison Samples, Rhea Xavier, Rakez Kayed

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: Alzheimer's disease (AD) is characterized by the accumulation of tau protein in the brain, which forms neurofibrillary tangles and contributes to the gradual deterioration of brain function. As a consequence, cellular senescence occurs, leading to cognitive impairment and hastening the aging process. Immunotherapies targeting Aβ and other protein aggregates are also being developed in the meantime. This study looks at immunotherapy in a Mapt (hTau) mouse model. This could become a useful immunological treatment in the future by lowering inflammation and cellular senescence that come with getting older. METHOD: Mapt (hTau) mice were inoculated in the hippocampus with 1 µg of brain-derived Tau oligomers (BDTOs) from AD patients. After seven months, mice were injected in the tail vein with 120 µg of in-house mouse monoclonal anti-toxic tau antibodies (TTCM1-2 and TOMA1-4) or IgG isotype control. Mice were evaluated for cognitive and motor function before euthanasia, and brain neuropathology was investigated with immunohistochemistry, immunofluorescence, and western blot techniques. RESULT: Treatment with anti-toxic tau antibodies reduced total tau levels and tau phosphorylation in the brain. Furthermore, immunotherapy reduced inflammation and cellular senescence markers. CONCLUSION: The observed decrease in tau aggregates following immunotherapy indicates that the mechanisms responsible for tau phosphorylation and/or aggregation may have been altered. Additionally, the decrease in senescence and inflammation markers suggests that immunotherapeutic strategies targeting tau are a promising approach in the management of tauopathies.

Original languageEnglish (US)
Pages (from-to)e089755
JournalAlzheimer's and Dementia
Volume20
DOIs
StatePublished - Dec 1 2024

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Basic Science and Pathogenesis'. Together they form a unique fingerprint.

Cite this